- Home
- LINE vs ICLR Comparison
LINE vs ICLR Comparison
Compare LINE & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LINE
- ICLR
- Stock Information
- Founded
- LINE 2012
- ICLR 1990
- Country
- LINE United States
- ICLR Ireland
- Employees
- LINE N/A
- ICLR N/A
- Industry
- LINE
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- LINE
- ICLR Health Care
- Exchange
- LINE NYSE
- ICLR Nasdaq
- Market Cap
- LINE 17.1B
- ICLR 17.5B
- IPO Year
- LINE 2024
- ICLR 1998
- Fundamental
- Price
- LINE $62.57
- ICLR $212.99
- Analyst Decision
- LINE Buy
- ICLR Strong Buy
- Analyst Count
- LINE 16
- ICLR 10
- Target Price
- LINE $90.75
- ICLR $290.60
- AVG Volume (30 Days)
- LINE 1.2M
- ICLR 1.6M
- Earning Date
- LINE 11-06-2024
- ICLR 10-23-2024
- Dividend Yield
- LINE 0.61%
- ICLR N/A
- EPS Growth
- LINE N/A
- ICLR 44.49
- EPS
- LINE N/A
- ICLR 8.99
- Revenue
- LINE $5,331,900,000.00
- ICLR $8,306,823,000.00
- Revenue This Year
- LINE N/A
- ICLR $3.95
- Revenue Next Year
- LINE $3.61
- ICLR $3.00
- P/E Ratio
- LINE N/A
- ICLR $23.76
- Revenue Growth
- LINE 8.19
- ICLR 3.63
- 52 Week Low
- LINE $62.43
- ICLR $183.38
- 52 Week High
- LINE $89.85
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- LINE N/A
- ICLR 42.59
- Support Level
- LINE N/A
- ICLR $209.13
- Resistance Level
- LINE N/A
- ICLR $216.75
- Average True Range (ATR)
- LINE 0.00
- ICLR 6.91
- MACD
- LINE 0.00
- ICLR 3.93
- Stochastic Oscillator
- LINE 0.00
- ICLR 78.00
About LINE LINEAGE INC
Lineage Inc is a Real Estate Investment Trust. The company is engaged in delivering end-to-end, technology-enabled, customer experience for thousands of customers with their customizations in the temperature-controlled supply chain to eliminate wastage of food. The services provided by the company are Cold Storage Warehousing, Automated Warehousing, Port-Centric Warehousing, Sustainable Warehousing, Freight Forwarding, Drayage, Customs Brokerage, and others.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.